Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland

Zubair Kabir1, Kathleen Bennett, Emer Shelley

  • 1Department of Pharmacology & Therapeutics, Trinity College & St. James's Hospital Dublin, Ireland. kabirzin@yahoo.com

Insights

Coronary heart disease (CHD) treatments and risk factor changes in Ireland significantly increased life expectancy. Reductions in cholesterol and smoking yielded more life-years gained than medical interventions alone.

Area of Science:

  • Cardiovascular epidemiology
  • Public health policy
  • Health economics

Background:

  • Coronary heart disease (CHD) mortality rates in Ireland have decreased significantly since the mid-1980s.
  • Adult life expectancy in Ireland has shown a steady improvement.

Purpose of the Study:

  • To estimate the life-years gained from CHD treatments.
  • To quantify the impact of changes in cardiovascular risk factor levels on life-years gained.

Main Methods:

  • Utilized the Irish IMPACT CHD mortality model.
  • Integrated data on patient numbers, treatment uptake, risk factor trends, treatment effectiveness, and survival rates.
  • Stratified analyses by age and sex, with sensitivity analyses performed.

Main Results:

  • Approximately 44,060 life-years were gained among individuals aged 25-84 between 1985 and 2000.
  • Cardiology treatments contributed around 14,505 life-years.
  • Risk factor reductions, particularly in cholesterol and smoking, accounted for approximately 32,705 life-years, with cholesterol reduction being the largest contributor.

Conclusions:

  • Modern cardiology treatments have substantially increased life-years in Ireland.
  • Risk factor reduction strategies have proven more effective in gaining life-years than treatments alone.
  • Future health gains depend on effective public health policies promoting healthy diets, weight reduction, and smoking cessation.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...